<DOC>
	<DOCNO>NCT01712321</DOCNO>
	<brief_summary>The purpose study determine whether Vilazodone effective treatment symptom Social Anxiety Disorder among adult .</brief_summary>
	<brief_title>Study Vilazodone Treat Social Anxiety Disorder</brief_title>
	<detailed_description>The propose study 12 week double-blind , placebo-controlled trial daily dose vilazodone 20 40 mg/day match placebo administer 1:1 ratio . The study include 30 outpatient age 18-75 SAD , generalize subtype return least one post randomization visit efficacy evaluation conduct .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Diagnosis Social Anxiety Disorder , generalize subtype LSAS total score 70 visit 1 2 Lifetime history Bipolar disorder Schizophrenia Current suicidal risk Current unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Social Anxiety Disorder</keyword>
	<keyword>Social Anxiety</keyword>
	<keyword>Social Phobia</keyword>
	<keyword>SAD</keyword>
</DOC>